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One of Two Unstructured Domains of Ii Becomes
Ordered in Complexes with MHC Class II Molecules
CLIP is subsequently replaced by antigenic peptides in
an exchange catalyzed by the class II±like molecule
HLA-DM (Denzin and Cresswell, 1995; Sherman et al.,
Alan Jasanoff,*²# Soyoun Song,* Aaron R. Dinner,*²
Gerhard Wagner,³ and Don C. Wiley*§‖
*Department of Molecular and Cellular Biology
²Committee on Higher Degrees in Biophysics 1995; Sloan et al., 1995 ).
MHC class II molecules require up to several days to³Department of Biological Chemistry and
Molecular Pharmacology form stable complexes with peptides in vitro (Sadegh-
Nasseri et al., 1994). By contrast, the process of peptideHarvard Medical School
§Howard Hughes Medical Institute loading onto class II molecules in professional antigen-
presenting cells takes only about 1±3 hr because of theHarvard University
Cambridge, Massachusetts 02138 participation of Ii and HLA-DM (Cresswell, 1985; Neefjes
et al., 1990). Although the molecular mechanisms by
which this rate enhancement is achieved are poorly un-
derstood, a necessary step is clearly the fast formationSummary
of Ii/class II complexes observed in the endoplasmic
reticulum (Teyton et al., 1990). Recent evidence thatWe studied the role of the invariant chain (Ii) protein's
tissue-specific and developmentally timed modulationstructure in its ability to form complexes with major
of protease activity can affect positive selection of CD41histocompatibility complex class II molecules. Multidi-
T cells specifically by altering the pattern of Ii degrada-mensional nuclear magnetic resonance experiments
tion (Nakagawa et al., 1998; Pierre and Mellman, 1998)demonstrated that Ii contains two unstructured, flexi-
suggests that the kinetics of Ii cleavage, as well as theble domains: a 39 residue sequence that contains a
kinetics of class II binding, is critical to Ii's chaperoninregion (CLIP) critical for Ii/class II complex formation
functions. Structural features of Ii, and in particular largeand becomes rapidly ordered when Ii/class II com-
segments of the protein that are apparently unstructuredplexes are assembled, and a 30 residue sequence that
in the intact molecule (Jasanoff et al., 1995; Park et al.,contains the insertion point for a protease inhibitor
1995), may account for the schedule of Ii proteolysisdomain included in an alternative splice form of Ii.
and for its rapid and promiscuous binding to MHC classMobility of these domains guarantees accessibility to
II variants in vivo.CLIP and the inhibitor insert, and ordering of the CLIP-
containing domain may provide protection against pro-
Results and Discussionteolysis and contribute, along with Ii's compact 118±
192 domain, to allotype-independent class II binding.
Ii Has Two Mobile Domains
We used heteronuclear nuclear magnetic resonance
Introduction (NMR) methods to delimit Ii's mobile segments. In spec-
tra of a 54 kDa histidine-tagged luminal domain of Ii (Ii
Antigen presentation by specialized cells in the immune h72±216 [Figure 1A]), only rapidly reorienting residues
system depends on the interplay of major histocompati- give rise to sharp NMR signals. Data from double- and
bility complex (MHC) class II molecules, which bind and triple-resonance experiments allowed us to assign the
present antigenic peptides, the two chaperone mole- sharp resonances (Figure 1B) and establish that they
cules invariant chain and HLA-DM, which regulate trans- correspond to two continuous mobile segments of Ii
port and peptide-loading of class II, and proteases, which h72±216: the 39 N-terminal residues 72±110, and the 30
degrade endocytosed proteins. Membrane-anchored Ii C-terminal residues 187±216. In these two segments
trimers form nonameric complexes with newly synthe- all residues were uniquely assigned, with the following
sized MHC ab heterodimers in the endoplasmic reticu- exceptions: prolines (which did not contribute to the
lum, mediated primarily by interactions between luminal 15N-separated spectra we used), K90, M91, R92, M104
portions of the molecules (Roche et al., 1991; Romagnoli [due to peak overlaps in HNCA and HN(CO)CA spectra],
and Germain, 1994; Newcomb et al., 1996). Directed by K81 and K83 (which are both flanked by prolines and
a targeting sequence at the cytoplasmic N terminus of can be assigned but not distinguished from each other),
Ii, (abIi)3 assemblies then migrate to trans-Golgi com- and M216, the C-terminal residue (tentatively assigned
partments. There Ii is proteolytically degraded, generat- only because of the apparent absence of a succeeding
ing complexes of class II ab with CLIP, a peptide drawn residue). The longest unassigned segment is three resi-
from residues in Ii (81±104) which drastically reduce dues (90±92) and it is highly unlikely for physical reasons
binding to class II when deleted (Bakke and Dob- that any of the unassigned residues could constitute
berstein, 1990; Lotteau et al., 1990; Avva and Cresswell, rigid interruptions to the otherwise continuous mobile
1994; Bijlmakers et al., 1994; Freisewinkel et al., 1993). regions.
In principle, it was possible that parts of the 39 residue
N-terminal segment or the 30 residue C-terminal seg-‖ To whom correspondence should be addressed (e-mail: dcwad
ment could form small compact domains connected tomin@crystal.harvard.edu).
the rest of the protein by flexible links; such minidomains# Present address: Whitehead Institute for Biomedical Research, 9
Cambridge Center, Cambridge, Massachusetts, 02142. would still be rapidly reorienting compared with the
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Figure 2. Chemical Shift Data and 15N-HSQC Spectra
(A) Ca secondary chemical shifts (solid line, left vertical axis) and
1H-15N heteronuclear NOE enhancements [XNOE 5 (Isat 2 I0) / I0]
(dashed line, right vertical axis) for assigned mobile residues (hori-
zontal axis) in Ii h72±216. Secondary chemical shifts are smallFigure 1. Primary Structure of Ii Molecules and NMR Sequential
throughout the 72±110 and 187±216 ranges. Dd of roughly 11 ppmAssignments
for residues 72±78 may indicate a slight helical propensity in this
(A) Primary structure of Ii molecules. Ii p31 is the major form of Ii in
region but may be an artifact of their proximity to the hexahistidine
vivo. The Ii cytoplasmic domain (1±32) includes a cellular localization
tag in Ii h72±216. These are also the residues with the smallest
signal, and the luminal domain (56±216) contains the CLIP segment
(least negative) XNOE enhancements. Calculation of (Isat 2 I0)/I0 is(81±104) and a trypsin-resistant trimerization domain (118±192). Ii
complicated by overlap of peaks in 1H-15N two-dimensional NMR
h58±218 includes an N-terminal hexahistidine tag sequence
spectra. The C-terminal residue M216 has the largest enhancement
(MRGSHHHHHHGSVD) followed by residues 58±216 of p31 Ii. Ii h72±
of 22.7 (not shown).
216 includes the same histidine tag sequence followed by residues
(B) 15N-HSQC spectra of nondeuterated Ii h72±216 (black) and Ii
72±216 of p31 Ii.
118±192 (red) at 500 MHz superimposed on the spectrum of mostly
(B) Strips showing the NMR resonances of 12 sequential residues
deuterated Ii h72±216 taken on a 750 MHz Varian Unity INOVA spec-
in 15N-TOCSY-HSQC and HNCA spectra. Specific identification of
trometer (blue). Almost all well-resolved peaks in the spectrum of
disordered residues in Ii h72±216 was accomplished using
Ii 118±192 correspond to small broad peaks that appear in the Ii15N-TOCSY-HSQC, 15N-NOESY-HSQC, HNCA, and HN(CO)CA ex-
h72±216 spectrum at high field, strongly suggesting that the com-
periments on uniformly 15N-labeled or 15N- and 13C-labeled protein.
pact trimeric 120±180 domain retains its structure in the context of
Sequential residues could be correlated through HN(i)-N(i)-Ca(i-1)
the longer Ii luminal domain molecules. 15N-HSQC spectra were also
peaks in the HNCA and HN(CO)CA, and in some cases through weak
obtained for deuterated and undeuterated Ii h72±216 at 750 MHz
(i, i11) NOEs as well. All spin systems in the TOCSY spectra matched
in the absence of t1 and t2 decoupling (data not shown); the distribu-patterns of resonances found in randomly coiled peptides (WuÈ thrich,
tion of line widths among each group of four crosspeaks per residue
1986), confirming that Ii residues contributing to the NMR spectra
in these spectra was not as would be expected if dipole±dipole
are disordered and simplifying assignment of each observed spin
coupling and chemical shift anisotropy provide the only significant
system or set of resonances to a specific residue type.
relaxation mechanisms, and TROSY-type experiments (Pervushin
et al., 1997) are therefore unlikely to provide further information
about the structured domain of Ii h72±216.compact trimerization domain and could contribute
sharp lines to spectra of Ii h72±216. Two lines of evi-
dence argue against this possibility (Figure 2A): (1) the would amino acid sequences with strong tendency to
form secondary structures, and (2) the 15N-1H hetero-Ca atoms of residues in the putative flexible segments
show no pronounced secondary chemical shifts, as nuclear NOE enhancements are severeÐmore negative
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than 21.0 for over 90% of those measuredÐfor residues
in the mobile segments, and thus show no evidence of
motionally restricted subdomains. The C terminus of Ii
h72±216 is identical to the C terminus of Ii in vivo, but
flexibility of the N-terminal region of the protein could
be an artifact of introducing a terminus at residue 72.
To address this possibility, we looked at spectra of a
longer construct, Ii h58±216, which includes all residues
N-terminal to the Ii transmembrane region, together with
an N-terminal histidine tag (Figure 1A). Although we did
not perform an independent assignment of peaks in the
Figure 3. Western Blot of a Nondenaturing Polyacrylamide GelIi h58±216 spectra, we found that 15N-HSQC spectra of
Showing Complex Formation between Ii h72±216 and HLA-DR1Ii h72±216 and Ii h58±216 could be superimposed, with
The anti-DR1 polyclonal antibody CHAMP was used to blot proteinsthe only major differences being apparent perturbations
transferred to polyvinylidene chloride. Numbers above lanes 1±7to the chemical shifts of residues 72±74 adjacent to the
denote the ratios (wt/wt) of DR1 to Ii h72±216. The DR1 concentration
added residues 58±71 and the presence of extra peaks was kept fixed at 270 mg/mL and the Ii concentrations were 920,
(at least 10), presumably due to further mobile residues 460, 180, 92, 37, 28, and 9.3 mg/mL in lanes 1±7, respectively. Lane
8 contains 920 mg/mL Ii h72±216 only and lane 9 contains 270 mg/in the 58±71 segment.
mL DR1 only. At low ratios of DR1 ab to Ii, only one DR1-containing
band is visible. At intermediate concentrations two new bands ap-Structure of Ii
pear and the lowest-mobility band predominates at high DR1/Ii ra-
Assignment of residues 72±110 and 187±216 to mobile tios. The highest- to lowest-mobility bands therefore correspond
segments of Ii h72±216 complements our recently pre- respectively to abIi3, (ab)2Ii3, and (abIi)3. The molecular weights of Ii
h72±216 and DR1 ab are 18 and 54 kDa, respectively. The highsented structure of the trimeric Ii 118±192 domain (Jasa-
ratios of DR1 to Ii h72±216 required to form complexes indicate thatnoff et al., 1998) to produce a virtually complete picture
over 50% of the DR1 did not participate in Ii binding. Size-exclusionof the conformation of Ii. Residues 181±192 at the C
chromatography indicates that that fraction is aggregated in prepa-terminus of Ii 118±192 are disordered in the isolated
rations of peptide-free DR1.
domain and overlap the C-terminal 187±216 disordered
segment we identified in Ii h72±216. Amino acids be-
tween P111 and K117 are the only residues in the Ii allotypes of class II, the CLIP sequence is required for
tight Ii/class II complex formation, and recent experi-luminal domain not accounted for either in assignment
of the flexible segments in Ii h72±216 or in the structure ments in which the CLIP region was modified or replaced
suggest that it does in fact bind to the class II peptide-of Ii 118±192. As a qualitative assurance that the struc-
ture of the 118±192 domain is the same in the longer binding groove in (abIi)3 nonamers (Stumptner and Ben-
aroch, 1997).protein as it is in its isolated form, we looked at the
15N-HSQC spectrum of z70% deuterated Ii h72±216 at
750 MHz (Figure 2B). The sharp peaks of the flexible The N-Terminal Ii Loop Becomes Ordered
in (abIi)3 Complexesresidues were visible as well as broad, faint peaks due
to the compact domain. Most peaks in the Ii 118±192 We formed complexes between recombinant Ii and pep-
tide-free (empty) HLA-DR1 class II molecules in vitro byspectrum corresponded closely with the broad peaks in
Ii h72±216 HSQC, strongly suggesting that the 118±192 mixing the two proteins and incubating them at room
temperature for 4 hr. The efficiency of complex forma-trimerization domain structure is preserved in the larger
protein. tion could be increased roughly 5-fold by the addition
of 5% isopropanol to mixtures of Ii and HLA-DR1. WeHow does the structure of Ii and in particular its mobile
domains facilitate interactions with MHC class II mole- confirmed by NMR that isopropanol had little effect on
the structure of Ii h72±216, so the effect of the alcoholcules and Ii function in antigen processing? The signifi-
cance of the 30 residue disordered C-terminal segment is probably either to solubilize a greater fraction of empty
DR1 molecules, which tend strongly to aggregate, or tomay lie in its ability to incorporate a 64 residue domain
that is inserted by differential splicing in the minor p41 influence a conformational equilibrium of empty DR1 to
favor Ii binding; alcohols and medium-length fatty acidsform of Ii but not in the major p31 form (from which the
Ii h72±216 sequence is drawn) (Koch et al., 1987). Ii p41 have been observed previously to stimulate peptide
binding to MHC (Avva and Cresswell, 1994). Figure 3accounts for widely varying fractions of total Ii in vivo,
depending on tissue type (Kampgen et al., 1991), and shows the Western blot of a nondenaturing gel of a
titration of empty class II with Ii h72±216, using a poly-its extra domain, a potent cathepsin L inhibitor (Bevec
et al., 1996), is the most highly conserved sequence in clonal antibody against HLA-DR1. Empty DR1 mole-
cules run as a diffuse smudge on the gel (lane 9) andIi. Incorporation of the p41 inhibitory domain into the
middle of the C-terminal loop (after residue 192) presum- lane 8, containing Ii h72±216 alone, does not blot. Three
DR1-containing bands are observed to varying extentsably disrupts only minimally the rest of the Ii protein. A
clear consequence of the presence of the N-terminal as the Ii h72±216 concentration is decreased from lanes
1 to 7. The uppermost band must be the nonamericdisordered segment spanning Ii residues 72±110 and
containing the CLIP region is that in the context of this complex and the lower two bands contain one and two
DR1 ab molecules per Ii trimer. The fact that abIi3, (ab)2Ii3,segment, Ii could potentially offer the CLIP residues
P87-A101 as an antigenic peptide surrogate for binding and (abIi)3 form progressively as the DR1 to Ii ratio in-
creases indicates that binding of each class II moleculein the MHC class II peptide-binding groove. For many
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Figure 4. NMR of HLA-DR Binding to Ii
(A) HSQC spectra of 0.2 mM 15N-labeled Ii h72±216 in the absence (left) and presence (right) of 10:1 (wt/wt) excess unlabeled HLA-DR1.
Residues whose 15N-TOCSY-HSQC signals diminish significantly on addition of DR1 are labeled in red in the spectrum of the complex. Spectra
were recorded on a Bruker DMX-500 spectrometer under the same conditions as Figure 1B. A small amount of uncomplexed Ii (less than
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to Ii is roughly independent and that nonameric (abIi)3 cells with leupeptin (Blum and Cresswell, 1988; Demotz
et al., 1994; Ghosh et al., 1995). The ordering of thesecomplex formation is not strongly cooperative in vitro.
The unfolded structure of Ii h72±216 changes dramati- residues in Ii/class II complexes observed here suggests
a reason for their relative stability against degradation,cally upon complex formation with HLA-DR1. Figure 4A
shows 15N-HSQC spectra of Ii h72±216 before (left panel) despite the fact that they are disordered in uncomplexed
Ii. A sequential Ii proteolysis pathway in which mem-and after (right panel) addition of excess DR1. Each
HN-N peak (one per residue) is labeled with the residue brane-anchored Ii fragments containing CLIP are the
last to be degraded may be important to ensure Ii cyto-number determined by the sequential assignment pro-
cedure. Many peaks are significantly diminished in the plasmic domain±directed retention of class II molecules
in endosomes until DM-catalyzed antigenic peptidespectrum of the complex (red labels in Figure 4A), indi-
cating that their corresponding backbone amide groups loading has taken place. Ordering of the 72±110 domain
may also be important in the kinetics of Ii/class II com-have become wholly or partially ordered in binding to
DR1. Peak volumes in the 15N-TOCSY-HSQC spectrum plex formation. We studied the kinetics of the disorder-
to-order transition in Ii h72±216 and Ii h58±216 and foundwere integrated above a threshold level and compared,
and percent peak volume changes for each assigned that with protein concentrations of 0.2 mM in both cases,
mobile segments became ordered within the 5 minresidue are shown in Figure 4B. It is clear from the chart
that amide peaks from the N-terminal mobile domain are ªdead timeº of the experiment (shown for Ii h58±216 in
Figure 4C). This is comparable to the rate of an initialall substantially diminished. By contrast, amide peaks in
the C-terminal disordered region are only slightly re- peptide interaction with empty class II molecules but
significantly faster than either their (probably first-order)duced and, in some cases, enhanced. This most likely
indicates that the entire N-terminal disordered region acquisition of SDS-resistance in vitro or their formation
of long-lived MHC/peptide complexes (Witt and McCon-acquires significant structure upon binding of Ii to DR1.
The fact that residues 187±216 do not also become nell, 1991; Sadegh-Nasseri et al., 1994). In binding to
class II, Ii may have a kinetic advantage over peptidesordered indicates that ordering of the Ii N terminus is
not a nonspecific effect due to viscosity or binding of the due to potentially cooperative binding of the compact
structured trimerization domain to class II. To determine trimerization domain, the CLIP region, and perhaps
that the ordering is not an artifact of the Ii h72±216 other elements of the 72±110 segment.
recombinant molecule, we also studied DR1 complex
formation with the longer Ii h58±216 (Figure 4C). A similar
Structure of (abIi)3large-scale change in peak volumes was observed, con-
What is the structure of the Ii/MHC class II complex?sistent with results from Ii h72±216.
Ordering of Ii residues 72±110 on (abIi)3 complex forma-The flexible domain that becomes ordered, Ii residues
tion indicates that these residues either contact class72±110, includes the CLIP residues (87±101) found in
II molecules directly or adopt an ordered conformationthe class II peptide-binding site of DR3/CLIP complexes.
induced by Ii's binding to DR1. Residues 87±101 in Ii'sThe domain also includes flanking residues found in LIP
CLIP region most probably bind in the class II peptide-and SLIP, 21 kDa and 12 kDa early intermediates in Ii
binding groove as in CLIP/class II complexes. But indegradation that retain the membrane anchor and
principle this places only mild conformational restraintswhose accumulation in complex with MHC class II mole-
cules can be induced by treatment of antigen-presenting on the geometry of the Ii/class II complex as a whole
15%) was detected by gel electrophoresis after the NMR experiment, despite the fact that the ratio of DR1 to Ii h72±216 was significantly
higher than that required for full complex formation according to Figure 2. This indicates that a lower fraction of empty DR1 was available
for binding Ii at the high concentration required for the NMR experiment (roughly 1 mM) than at the concentration used for the gel in Figure
2 (roughly 5 mM). Vestigial peaks at the chemical shift values of Ii h72±216 resonances, which significantly diminish on Ii/DR1 complex
formation, are most likely due to the small amount of uncomplexed Ii.
(B) Percent change in the total volume of 15N-TOCSY-HSQC peaks for each disordered residue in Ii h72±216 on complex formation with HLA-
DR1. Because visible peak intensity arises only from mobility of residues in Ii h72±216, decreases in the volume of the TOCSY peaks indicate
partial ordering of the corresponding residues. NMR samples were the same as in (A). TOCSY-HSQC spectra were acquired, processed, and
integrated identically for Ii h72±216 alone and Ii/DR1 complexes. Residues are color-coded as follows: black, assigned residues in double-
and triple-resonance spectra of Ii h72±216; green, prolines (not observable in the 15N-separated NMR spectra we used); blue, ambiguously
assigned residues K83, K86, and M216; yellow, unassigned residues in the flexible domains 72±110 and 187±216; and red, unassigned residues
in (boxed) or flanking the Ii 118±192 trimerization domain (also red in Figure 1A). A horizontal bar marks Ii residues 87±101 observed in the
crystal structure of HLA-DR3 complexed with CLIP peptide. Residues 120±180 form a well-ordered trimeric structure (ribbon diagram), which
we recently determined from NMR studies of Ii 118±192. Residues 118±119 and 181±184 are disordered in this molecule but show some
evidence of partial structure and could not be assigned in spectra of Ii h72±216. Residues 185±192 are completely disordered in Ii 118±192
and overlap the C-terminal 187±216 domain of Ii h72±216, which we show here to be disordered. Residues 114 and 120 are glycosylation
sites, and residue 110 is a proteinase K cleavage site in abIi complexes (Machamer and Cresswell, 1982; Newcomb et al., 1996), suggesting
that the 111±120 region that is unassigned in Ii h72±216 is exposed both in free Ii and in abIi complexes. Peak volumes and percent changes
reported here may be affected by overlap of resonances in the TOCSY spectra. Increases in the peak volumes for some residues in the
187±216 sequence probably reflect uncertainty in the measurement as opposed to an ªincrease in mobility.º Resonances corresponding to
T187 in the 15N-TOCSY-HSQC spectrum decrease more significantly on Ii/DR1 complex formation than its resonance in the HSQC spectra of
(A); its proximity to the ordered trimerization domain may be significant, particularly if (as is likely) the trimerization domain interacts directly
with class II heterodimers.
(C) Portions of the 15N-HSQC spectra of 15N-labeled Ii h58±216 initiated before addition of 15:1 (wt/wt) excess unlabeled HLA-DR1 (left panel)
15 min after mixing (middle panel) and 15 hr after mixing (right panel). Peaks that diminish significantly after addition of DR1 are noted by red
crosses. There are no notable differences between Ii h58±216 HSQC spectra (20 min acquisition time) initiated 15 min and 15 hr after mixing.
Immunity
766
Figure 5. Geometry of Complex Formation
between Ii and MHC Class II Molecules
(A) Ribbon diagram of an Ii homotrimer with
the N- and C-terminal mobile domains of the
red protomer rendered as extended polypep-
tide chains and drawn roughly to scale (3.5 AÊ
per extended residue). The N-terminal mobile
domain contains residues 72±110, of which
residues 87±101 (gray ribbon) in the CLIP re-
gion probably bind in the peptide-binding
groove of an MHC class II molecule (green
ribbon structure) in (abIi)3 complexes. Resi-
dues 58±71 (dashed line) give rise to peaks
in the HSQC spectra of the long Ii construct
Ii h58±216 and are probably also flexible. Res-
idues 111±119 and 181±186 (red line seg-
ments) do not give rise to assigned reso-
nances in spectra of Ii h72±216 but do not
form compact structure (residues 120±180,
red ribbon) in the Ii trimerization domain.
C-terminal residues 187±216 are assigned and mobile in Ii h72±216. The N terminus of Ii and C termini of class II ab are membrane proximal
(bottom of figure). The diagram indicates that the mobile portions of Ii are long with respect to the heights of Ii (25 AÊ ) and MHC class II
molecules (75 AÊ ) and that many Ii/class II interaction geometries are consistent with simultaneous interaction of MHC class II with Ii's CLIP
region and compact domain.
(B) Schematic depiction of hypothetical nonameric (abIi)3 structures in which the N-terminal ordering domains (black strands) of Ii (compact
domain in red) approach each other as they enter the plasma membrane (upper panel) or diverge and enclose three (green) class II molecules
(lower panel). A complex with the geometry of the upper panel would be easier to assemble. The Ii N-terminal domains might interact directly
or indirectly with the class II molecules in either complex geometry (no specific model shown). C-terminal flexible domains have been omitted
for simplicity.
because of the length of the Ii N-terminal unfolded seg- abrogates class II binding of Ii 103±216 (C-terminal to
CLIP) (Thayer et al., 1999), (3) a peptide correspondingment (Figure 5A). Assuming an extended chain length
of about 3.5 AÊ per residue (Creighton, 1993), the 39 to Ii residues 71±88 binds HLA-DR2 with micromolar
affinity noncompetitively at the same time as groove-residue 72±110 segment could be over 130 AÊ long. Resi-
dues 72±86 can stretch 50 AÊ , and with the likely addi- binding peptides (Vogt et al., 1995), and (4) a peptide
containing Ii residues 81±89 promotes CLIP dissociationtional flexibility of residues 58±71, there can be over
100 AÊ of unfolded polypeptide between Ii's transmem- from DR3 complexes in trans (Kropshofer et al., 1995). In
contrast to these earlier data, observation of the 72±110brane region and the class II groove binding residues
87±101. These length considerations admit the possibil- disorder-to-order transition in the context of class II/Ii
h72±216 complexes shows that all of the Ii residuesity that in the (abIi)3 nonamer an Ii trimer ªenclosesº
three class II molecules by passing its N-terminal seg- thought to interact with class II can participate in interac-
tions simultaneously in a virtually intact Ii molecule. Thements over them and forming a ring of its three trans-
membrane regions around the class II transmembrane ability of Ii to present an extended and initially flexible
interaction surface, as well as a high-affinity class IIregions (Figure 5B, bottom). We consider it more likely
that three class II molecules in (abIi)3 enclose the three groove-binding sequence, could allow the protein to
chelate a wide variety of class II molecules with highIi N-terminal segments (Figure 5B top); such a complex
could be more easily assembled and is more easily rec- affinity and enhance Ii's ability to function as an allotype-
independent class II chaperone.onciled with evidence that the Ii transmembrane tri-
merizes. Finally, it should be noted that because of the
unfolded segment C-terminal to CLIP, occupancy of the
Experimental Proceduresclass II binding site by the Ii 87±101 sequence is consis-
tent with a wide variety of interaction geometries be- Protein Purification and Ii/HLA-DR1 Complex Formation
tween class II and the compact Ii C-terminal trimeriza- The soluble Ii luminal domains, Ii h58±216 and Ii h72±216 (Figure
1A), were produced from recombinant Escherichia coli (strain XA90)tion domain, which is also known to form nonameric
and purified by Ni-affinity (Qiagen) and anion exchange chromatog-complexes with class II molecules (Newcomb et al.,
raphy (Pharmacia). Isotopically labeled molecules were produced1996).
by growing recombinant bacteria on M9 minimal medium at 308C,Observation of a disorder-to-order transition of the
with 1.0 g/L 15NH4Cl, 1.2 g/L 13C6-glucose, or D2O (Cambridge Isotopeentire 72±110 segment in Ii h72±216/DR1 complex for- Laboratories) as medium components, depending on the desired
mation provides the first direct structural evidence for labeling pattern. MHC class II HLA-DR1 molecules were produced
and secreted by recombinant S2 Schneider cells and immunoaffinityinvolvement of non±groove binding CLIP residues (87±
purified from the culture medium (Sloan et al., 1995).101) in MHC class II complex formation with Ii. Prior
Complexes were formed by incubating mixtures of Ii and DR1 inindications that Ii residues in 72±110 may interact with
phosphate-buffered saline solution (pH 6.7) in the presence of 5%class II have included findings that (1) deletion of resi-
isopropanol and protease inhibitors aprotinin, leupeptin, and EDTA
dues 81±87 abrogates class II binding activity of an Ii (Sigma) at standard concentrations. In the absence of the alcohol,
already missing CLIP groove-binding residues (Sieben- complexes could also be formed, but with much lower yield. Prod-
ucts of the Ii/DR1 association were resolved by nondenaturing 10%kotten et al., 1998), (2) deletion of residues 103±117
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polyacrylamide gel electrophoresis and either stained with Coomas- Bakke, O., and Dobberstein, B. (1990). MHC class II-associated
invariant chain contains a sorting signal for endosomal compart-sie blue or transferred to a polyvinylidene membrane and visualized
ments. Cell 63, 707±716.with rabbit polyclonal anti-DR1 antibody (CHAMP) and alkaline
phosphatase-conjugated goat anti-rabbit secondary antibody (Boeh- Bevec, T., Stoka, V., Pungercic, G., Dolenc, I., and Turk, V. (1996).
ringer Mannheim). Major histocompatibility complex class II-associated p41 invariant
chain fragment is a strong inhibitor of lysosomal cathepsin L. J.
Exp. Med. 183, 1331±1338.NMR Spectroscopy
NMR experiments were performed with Ii concentrations of 0.2±1.0 Bijlmakers, M.J., Benaroch, P., and Ploegh, H.L. (1994). Mapping
mM at 278C in phosphate-buffered saline solution (pH 6.7) with 5% functional regions in the lumenal domain of the class II-associated
perdeuterated isopropanol and standard concentrations of apro- invariant chain. J. Exp. Med. 180, 623±629.
tinin, leupeptin, and EDTA. On a Bruker DMX-500 spectrometer, Blum, J.S., and Cresswell, P. (1988). Role for intracellular proteases
15N-HSQC, 15N TOCSY-HSQC, and 15N NOESY-HSQC spectra were in the processing and transport of class II HLA antigens. Proc. Natl.
obtained with 15N-labeled Ii h72±216 and Ii h58±216 in the presence Acad. Sci. USA 85, 3975±3979.
and absence of excess HLA-DR1 (10±15:1 wt/wt), and also with Ii
Creighton, T.E. (1993). Proteins: Structures and Molecular Properties
h72±216 in the absence of the isopropanol; HNCA and HN(CO)CA (Freeman: New York).
experiments were performed with 15N,13C-labeled Ii h72±216. Ca
Cresswell, P. (1985). Intracellular class II HLA antigens are accessi-chemical shifts were referenced to tetramethylsilane with external
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